Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

IntroductionTriple-negative breast cancer (TNBC) patients who do not obtain pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) present higher rate of relapse and worse overall survival. Risk factors for relapse in this subset of patients are poorly characterized. This study a...

Full description

Bibliographic Details
Main Authors: Angela Toss, Marta Venturelli, Monica Civallero, Claudia Piombino, Federica Domati, Guido Ficarra, Francesca Combi, Eleonora Cabitza, Federica Caggia, Elena Barbieri, Monica Barbolini, Luca Moscetti, Claudia Omarini, Federico Piacentini, Giovanni Tazzioli, Massimo Dominici, Laura Cortesi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
triple-negative breast cancer
neoadjuvant chemotherapy
pathologic response
residual cancer burden (RCB)
multifocal disease
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1016295/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1016295/full

Similar Items